Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: Comparison with double J stent insertion

Hwan Hoon Chung, Man Deuk Kim, Jong Yun Won, Je Hwan Won, Sung Bum Cho, Tae-Seok Seo, Sang Woo Park, Byung Chul Kang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: This study was designed to evaluate the effectiveness of the newly designed covered metallic stent (CMS) for malignant ureteral obstruction by comparing with double J stent (DJS). Material and Methods: CMSs were placed for malignant ureteral obstruction caused by various types of cancers for 42 ureters in 32 patients from 7 institutes. Retrospective data were collected for DJSs, which included 72 malignant ureteral occlusions in 56 patients from a single institute. Twenty-seven DJSs were placed percutaneously, and 45 DJSs were cystoscopically inserted. Technical failure of the CMS group was compared with that of the radiologically inserted DJS group. Primary patency of the CMS group was compared with assisted primary patency of the DJS group. Results: Technical failure of the CMS group is lower than that of the radiologically inserted DJS group: 0 % (0/42) vs. 25.9 % (7/27; p = 0.002), respectively. Primary patency of the CMS group is better than assisted primary patency of the DJS group (p = 0.012). Primary patency of the CMSs is 100, 94.5, 74.7, 70.3, 65.3, 65.3, and 65.3 % at 1, 3, 6, 9, 12, 18, and 24 months, respectively. Assisted primary patency of the DJS is 78.6, 75.1, 59.1, 48.7, 38.7, and 37.8 % at 1, 3, 6, 9, 12, and 18 months, respectively. No serious complications were noted in the CMS group. Migration of the metallic stent occurred in one patient (2.3 %). Conclusions: Covered metallic stent placement for malignant ureteral obstruction is superior to the double J stent placement in terms of technical success and patency.

Original languageEnglish
Pages (from-to)463-470
Number of pages8
JournalCardioVascular and Interventional Radiology
Volume37
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Stents
Ureteral Obstruction
Ureteral Neoplasms

Keywords

  • Interventional procedures
  • Stents
  • Ureter

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion : Comparison with double J stent insertion. / Chung, Hwan Hoon; Kim, Man Deuk; Won, Jong Yun; Won, Je Hwan; Cho, Sung Bum; Seo, Tae-Seok; Park, Sang Woo; Kang, Byung Chul.

In: CardioVascular and Interventional Radiology, Vol. 37, No. 2, 01.01.2014, p. 463-470.

Research output: Contribution to journalArticle

@article{41e90104126840f0a4d9de7305387394,
title = "Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: Comparison with double J stent insertion",
abstract = "Purpose: This study was designed to evaluate the effectiveness of the newly designed covered metallic stent (CMS) for malignant ureteral obstruction by comparing with double J stent (DJS). Material and Methods: CMSs were placed for malignant ureteral obstruction caused by various types of cancers for 42 ureters in 32 patients from 7 institutes. Retrospective data were collected for DJSs, which included 72 malignant ureteral occlusions in 56 patients from a single institute. Twenty-seven DJSs were placed percutaneously, and 45 DJSs were cystoscopically inserted. Technical failure of the CMS group was compared with that of the radiologically inserted DJS group. Primary patency of the CMS group was compared with assisted primary patency of the DJS group. Results: Technical failure of the CMS group is lower than that of the radiologically inserted DJS group: 0 {\%} (0/42) vs. 25.9 {\%} (7/27; p = 0.002), respectively. Primary patency of the CMS group is better than assisted primary patency of the DJS group (p = 0.012). Primary patency of the CMSs is 100, 94.5, 74.7, 70.3, 65.3, 65.3, and 65.3 {\%} at 1, 3, 6, 9, 12, 18, and 24 months, respectively. Assisted primary patency of the DJS is 78.6, 75.1, 59.1, 48.7, 38.7, and 37.8 {\%} at 1, 3, 6, 9, 12, and 18 months, respectively. No serious complications were noted in the CMS group. Migration of the metallic stent occurred in one patient (2.3 {\%}). Conclusions: Covered metallic stent placement for malignant ureteral obstruction is superior to the double J stent placement in terms of technical success and patency.",
keywords = "Interventional procedures, Stents, Ureter",
author = "Chung, {Hwan Hoon} and Kim, {Man Deuk} and Won, {Jong Yun} and Won, {Je Hwan} and Cho, {Sung Bum} and Tae-Seok Seo and Park, {Sang Woo} and Kang, {Byung Chul}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00270-013-0675-2",
language = "English",
volume = "37",
pages = "463--470",
journal = "Cardiovascular Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion

T2 - Comparison with double J stent insertion

AU - Chung, Hwan Hoon

AU - Kim, Man Deuk

AU - Won, Jong Yun

AU - Won, Je Hwan

AU - Cho, Sung Bum

AU - Seo, Tae-Seok

AU - Park, Sang Woo

AU - Kang, Byung Chul

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose: This study was designed to evaluate the effectiveness of the newly designed covered metallic stent (CMS) for malignant ureteral obstruction by comparing with double J stent (DJS). Material and Methods: CMSs were placed for malignant ureteral obstruction caused by various types of cancers for 42 ureters in 32 patients from 7 institutes. Retrospective data were collected for DJSs, which included 72 malignant ureteral occlusions in 56 patients from a single institute. Twenty-seven DJSs were placed percutaneously, and 45 DJSs were cystoscopically inserted. Technical failure of the CMS group was compared with that of the radiologically inserted DJS group. Primary patency of the CMS group was compared with assisted primary patency of the DJS group. Results: Technical failure of the CMS group is lower than that of the radiologically inserted DJS group: 0 % (0/42) vs. 25.9 % (7/27; p = 0.002), respectively. Primary patency of the CMS group is better than assisted primary patency of the DJS group (p = 0.012). Primary patency of the CMSs is 100, 94.5, 74.7, 70.3, 65.3, 65.3, and 65.3 % at 1, 3, 6, 9, 12, 18, and 24 months, respectively. Assisted primary patency of the DJS is 78.6, 75.1, 59.1, 48.7, 38.7, and 37.8 % at 1, 3, 6, 9, 12, and 18 months, respectively. No serious complications were noted in the CMS group. Migration of the metallic stent occurred in one patient (2.3 %). Conclusions: Covered metallic stent placement for malignant ureteral obstruction is superior to the double J stent placement in terms of technical success and patency.

AB - Purpose: This study was designed to evaluate the effectiveness of the newly designed covered metallic stent (CMS) for malignant ureteral obstruction by comparing with double J stent (DJS). Material and Methods: CMSs were placed for malignant ureteral obstruction caused by various types of cancers for 42 ureters in 32 patients from 7 institutes. Retrospective data were collected for DJSs, which included 72 malignant ureteral occlusions in 56 patients from a single institute. Twenty-seven DJSs were placed percutaneously, and 45 DJSs were cystoscopically inserted. Technical failure of the CMS group was compared with that of the radiologically inserted DJS group. Primary patency of the CMS group was compared with assisted primary patency of the DJS group. Results: Technical failure of the CMS group is lower than that of the radiologically inserted DJS group: 0 % (0/42) vs. 25.9 % (7/27; p = 0.002), respectively. Primary patency of the CMS group is better than assisted primary patency of the DJS group (p = 0.012). Primary patency of the CMSs is 100, 94.5, 74.7, 70.3, 65.3, 65.3, and 65.3 % at 1, 3, 6, 9, 12, 18, and 24 months, respectively. Assisted primary patency of the DJS is 78.6, 75.1, 59.1, 48.7, 38.7, and 37.8 % at 1, 3, 6, 9, 12, and 18 months, respectively. No serious complications were noted in the CMS group. Migration of the metallic stent occurred in one patient (2.3 %). Conclusions: Covered metallic stent placement for malignant ureteral obstruction is superior to the double J stent placement in terms of technical success and patency.

KW - Interventional procedures

KW - Stents

KW - Ureter

UR - http://www.scopus.com/inward/record.url?scp=84897090290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897090290&partnerID=8YFLogxK

U2 - 10.1007/s00270-013-0675-2

DO - 10.1007/s00270-013-0675-2

M3 - Article

C2 - 23925919

AN - SCOPUS:84897090290

VL - 37

SP - 463

EP - 470

JO - Cardiovascular Radiology

JF - Cardiovascular Radiology

SN - 7415-5101

IS - 2

ER -